Current Research Information SysTem In Norway
 
 

 English version


 
Hovedside
Forskningsresultater/NVI
Forskere
Prosjekter
Forskningsenheter
Logg inn
Om Cristin
 
 
   
Eksporter til


Viser treff 1-50 av 68 << Forrige 1 2    Neste >>

2018
1 Rekeland, Ingrid Gurvin; Fluge, Øystein; Alme, Kine; Risa, Kristin; Sørland, Kari; Mella, Olav; de Vries, Annick; Schjøtt, Jan.
Rituximab Serum Concentrations and Anti-Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue Syndrome. Clinical Therapeutics 2018
HAUKELAND UiB Untitled
 
2017
2 Fluge, Øystein; Mannsåker, Bård; Torp, Anders; Mjaaland, Ingvil; Helgeland, Lars; Klos, Jan; Mella, Olav; Berentsen, Sigbjørn; Meyer, Peter Albert.
Consolidative radiotherapy to residual masses after chemotherapy is associated with improved outcome in diffuse large B-cell lymphoma. A retrospective, population-based study. Clinical Lymphoma, Myeloma & Leukemia 2017 ;Volum 18.(2) s. 125-135
HAUKELAND HELSEFONNA NLSH SSHF SUS Untitled
 
3 Tronstad, Karl Johan; Fluge, Øystein; Lien, Katarina; Sommerfelt, Kristian; Mella, Olav.
Mer om pyruvat dehydrogenase og kronisk utmattelsessyndrom.. Tidsskrift for Den norske legeforening 2017
UiB UiO Untitled
 
4 Tronstad, Karl Johan; Fluge, Øystein; Mella, Olav.
Chronic fatigue syndrome and pyruvate dehydrogenase function.. Tidsskrift for Den norske legeforening 2017
UiB Untitled
 
5 Tronstad, Karl Johan; Fluge, Øystein; Mella, Olav.
Kronisk utmattelsessyndrom og pyruvat dehydrogenasefunksjon. Tidsskrift for Den norske legeforening 2017 ;Volum 138.(1)
UiB Untitled
 
2016
6 Fluge, Øystein; Mella, Olav; Bruland, Ove; Risa, Kristin; Dyrstad, Sissel Elisabeth; Alme, Kine; Rekeland, Ingrid Gurvin; Sapkota, Dipak; Røsland, Gro Vatne; Fosså, Alexander; Ktoridou-Valen, Irini; Lunde, Sigrid; Sørland, Kari; Lien, Katarina; Herder, Ingrid; Thurmer, Hanne; Gotaas, Merete E; Baranowska, Katarzyna Anna; Bohnen, Louis M.L.J.; Schäfer, Christoph; Mccann, Adrian; Sommerfelt, Kristian; Helgeland, Lars; Ueland, Per Magne; Dahl, Olav; Tronstad, Karl Johan.
Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.. JCI Insight 2016 ;Volum 1.
HAUKELAND OUS STHF UiB UiO UiT Untitled
 
7 Loebel, Madlen; Grabowski, Patricia; Heidecke, Harald; Bauer, Sandra; Hanitsch, Leif G.; Wittke, Kirsten; Meisel, Christian; Reinke, Petra; Volk, Hans-Dieter; Fluge, Øystein; Mella, Olav; Scheibenbogen, Carmen.
Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. Brain, behavior, and immunity 2016 ;Volum 52. s. 32-39
HAUKELAND UiB Untitled
 
8 Lunde, Sigrid; Kristoffersen, Einar Klæboe; Sapkota, Dipak; Risa, Kristin; Dahl, Olav; Bruland, Ove; Mella, Olav; Fluge, Øystein.
Serum BAFF and APRIL levels, T-lymphocyte subsets, and immunoglobulins after B-cell depletion using the monoclonal anti-CD20 antibody rituximab in myalgic encephalopathy/chronic fatigue syndrome. PLoS ONE 2016 ;Volum 11:e0161226.(8)
HAUKELAND UiB Untitled
 
2015
9 Fluge, Øystein; Risa, Kristin; Lunde, Sigrid; Alme, Kine; Rekeland, Ingrid Gurvin; Sapkota, Dipak; Kristoffersen, Einar Klæboe; Sørland, Kari; Bruland, Ove; Dahl, Olav; Mella, Olav.
B-lymphocyte depletion in myalgic encephalopathy/chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment. PLoS ONE 2015 ;Volum 10:e0129898.(7)
HAUKELAND UiB Untitled
 
2014
10 Arving, Cecilia; Thormodsen, Inger; Aaslund, Mona Kristin; Berntsen, Sveinung; Mella, Olav; Nordin, Karin.
“The prevalence of distress, emotional reactivity, fatigue and health related quality of life among newly diagnosed cancer patients starting adjuvant treatment”.. European Cancer Rehabilitation & Survivorship Symposium; 2014-09-08 - 2014-09-09
HAUKELAND UIA UiB Untitled
 
11 Waldeland, Einar; Dahl, Olav; Odland, Odd Harald; Kvaløy, Stein Olav; Lund, Jo-Åsmund; Malinen, Eirik; Marienhagen, Kirsten; Sylvarnes, Rune; Muren, Ludvig Paul; Pedersen, Geir; Pedersen, Brit; Vadset, Pål Ove; Wanderås, Anne Dybdahl; Mella, Olav.
Particle therapy in Norway - report from the national project group. Radiotherapy and Oncology 2014 ;Volum 111. Suppl. 1 s. 314-314
NTNU OUS STO UiB UiO UiT UNN Untitled
 
2013
12 Arving, Cecilia; Thormodsen, Inger; Brekke, Guri; Mella, Olav; Berntsen, Sveinung; Nordin, Karin.
Early rehabilitation of cancer patients - a randomized controlled intervention study. BMC Cancer 2013 ;Volum 13. s. -
HAUKELAND UIA UiB Untitled
 
2012
13 Westermann, Anneke; Mella, Olav; Van der Zee, Jacoba; Jones, Ellen L.; Van der Steen-Banasik, Elzbieta; Koper, Peter; Uitterhoeve, Appolina L.J.; de Wit, Ronald; van der Velden, Jacobus; Burger, Curt; Schem, Baard-Christian; Van der Wilt, Clasina L.; Dahl, Olav; Prosnitz, Leonard R.; van Tinteren, Harm.
Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an update. International Journal of Hyperthermia 2012 ;Volum 28.(6) s. 549-553
HAUKELAND UiB Untitled
 
2011
14 Fluge, Øystein; Bruland, Ove; Risa, Kristin; Storstein, Anette; Kristoffersen, Einar Klæboe; Sapkota, Dipak; Næss, Halvor; Dahl, Olav; Nyland, Harald Inge; Mella, Olav.
Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLoS ONE 2011 ;Volum 6.(10) s. -
HAUKELAND UiB Untitled
 
2009
15 Borkamo, Erling Dahl; Schem, Baard-Christian; Fluge, Øystein; Bruland, Ove; Dahl, Olav; Mella, Olav.
cDNA microarray analysis of serially sampled cervical cancer specimens from patients treated with thermochemoradiotherapy. International Journal of Radiation Oncology, Biology, Physics 2009 ;Volum 75.(5) s. 1562-1569
HAUKELAND UiB Untitled
 
16 Dahl, Inger Marie S.; Wisløff, Finn; Børset, Magne; Mella, Olav.
Myelomatose. I: Medikamentell kreftbehandling. Cytostatikaboken. Oslo: Farmakologisk institutt, DMF, UiO 2009 ISBN 978-829923312-5. s. 346-356
NTNU Untitled
 
17 Fluge, Øystein; Mella, Olav.
Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series. BMC Neurology 2009 ;Volum 9. s. -
HAUKELAND UiB Untitled
 
18 Haldorsen, Ingfrid Salvesen; Kråkenes, Jostein; Krossnes, Bård Kronen; Mella, Olav; Espeland, Ansgar.
CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. American Journal of Neuroradiology 2009 ;Volum 30.(4) s. 744-751
HAUKELAND OUS UiB Untitled
 
19 Overgaard, Jens; Gonzalez-Gonzales, Dionisio; Hulshof, Maarten C.C.H.; Arcangeli, Giorgio; Dahl, Olav; Mella, Olav; Bentzen, Søren M..
Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicenter randomized trial by The European Society for Hyperthermic Oncology. International Journal of Hyperthermia 2009 ;Volum 25.(5) s. 323-334
HAUKELAND Untitled
 
2008
20 Borkamo, Erling Dahl; Fluge, Øystein; Mella, Olav; Akslen, Lars A.; Bruland, Ove; Dahl, Olav.
Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour. Radiotherapy and Oncology 2008 ;Volum 86.(3) s. 435-442
HAUKELAND UiB Untitled
 
21 Haldorsen, Ingfrid Salvesen; Kråkenes, Jostein; Goplen, Anne K.; Dunlop, Oona; Mella, Olav; Espeland, Ansgar.
AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003. BMC Cancer 2008 ;Volum 8. s. -
HAUKELAND OUS UiB Untitled
 
2004
22 Haldorsen, Ingfrid Salvesen; Aarseth, Jan H; Hollender, Aase; Larsen, John Ludvig; Espeland, Ansgar; Mella, Olav.
Incidence, Clinical Features, Treatment and Outcome of Primary Central Nervous System Lymphoma in Norway. Acta Oncologica 2004 ;Volum 43. s. 520-529
HAUKELAND OUS UiB Untitled
 
23 Kolstad, Arne; Risberg, Terje; Bremnes, Yngve; Wilsgaard, Tom; Holte, Harald; Klepp, Olbjørn; Mella, Olav; Wist, Erik.
Use of complementary and alternative therapies: a national multicentre study of oncology health professionals in Norway. Supportive Care in Cancer 2004 ;Volum 12.(5) s. 312-318
OUS STO UiB UiT UNN Untitled
 
24 Krossnes, Bård Kronen; Mella, Olav; Wester, Knut; Mørk, Sverre.
Pigmented astrocytoma with suprasellar location: case report and literature review. Acta Neuropathologica 2004 ;Volum 5. s. 461-466
HAUKELAND UiB Untitled
 
25 Risberg, Terje; Bremnes, Yngve; Kolstad, Arne; Holte, Harald; Wist, Erik; Mella, Olav; Klepp, Olbjørn.
Tilbud om komplementær behandling i sykehus?. Tidsskrift for Den norske legeforening 2004 ;Volum 124. s. 3078-3080
OUS STO UiB Untitled
 
26 Risberg, Terje; Bremnes, Yngve; Kolstad, Arne; Holte, Harald; Wist, Erik; Mella, Olav; Klepp, Olbjørn.
Tilbud om komplementærbehandling i sykehus. Tidsskrift for Den norske legeforening 2004 ;Volum 124. s. 3078-3080
UiO Untitled
 
27 Risberg, Terje; Kolstad, Arne; Bremnes, Yngve; Holte, Harald; Wist, Erik; Mella, Olav; Klepp, Olbjørn; Wilsgaard, Tom; Cassileth, B.R..
Knowledge of and attitudes toward complementary and alternative therapies: a national multicentre study of oncology professionals in Norway. European Journal of Cancer 2004 ;Volum 40. s. 529-535
OUS STO UiB UiO UiT UNN Untitled
 
2003
28 Larsen, Annette; Schem, Baard-Christian; Ekanger, Roald; Mella, Olav.
Regional hyperthermia in addition to chemoradiotherapy in cervical cancer: results of a phase II-study. Nordic Society for Gynecologic Oncology; 2003-03-28 - 2003-03-29
UiB Untitled
 
29 NLG, The Nordic Lymphoma Group; Mella, Olav.
CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial. Blood 2003 ;Volum 101.(10) s. 3840-3848
UiB Untitled
 
30 Risberg, Terje; Kolstad, Arne; Wist, Erik; Holte, Harald; Mella, Olav; Klepp, Olbjørn.
Should alternative therapists treat cancer-what is the opinion of oncology health personnel?. Tidsskrift for Den norske legeforening 2003 ;Volum 123.(21) s. 3059-3061
OUS UiB Untitled
 
31 Risberg, Terje; Kolstad, Arne; Wist, Erik; Holthe, Harald; Mella, Olav; Klepp, Olbjørn.
Skal alternative utøvere behandle kreft - hva mener onkologiske helsearbeidere?. Tidsskrift for Den norske legeforening 2003 ;Volum 123. s. 3059-3061
NTNU UiB UiO Untitled
 
32 Schem, Baard-Christian; Froystein, T.; Hjertaker, B. T.; Larsen, Annette; Mella, Olav.
Trimodality treatment with regional hyperthermia, radiotherapy and chemotherapy in primary inoperable or recurrent rectal carcinoma. 21th Annual Meeting of the European Society for Hyperthermic Oncology; 2003-06-04 - 2003-06-07
UiB Untitled
 
33 Schem, Baard-Christian; Larsen, Annette; Froystein, T.; Hjertaker, B. T.; Mella, Olav.
Regional hyperthermia in addition to chemoradiotherapy in cervical carcinoma: Results of a phase II study. 14 th BSD Users Conference; 2003-10-30 - 2003-11-01
UiB Untitled
 
34 Schem, Baard-Christian; Larsen, Annette; Froystein, T.; Hjertaker, B. T.; Mella, Olav.
Trimodality treatment of inoperable/locally recurrent rectal cancer with hyperthermia, radiotherapy and chemotherapy. Pilot studies. 14th BSD Users Conference; 2003-10-30 - 2003-11-01
UiB Untitled
 
35 Westermann, Anneke M.; Jones, Ellen; Schem, Baard-Christian; Van der Zee, Jacoba; Van der Steen-Banasik, Elzbieta; Koper, Peter; Mella, Olav; Uitterhoeve, Lon J.; de Wit, Ronald; VAn der Velden, Ko; Burger, Curt; Van der Wilt, C. L.; Dahl, Olav; Prosnitz, Leonard R..
Regional hyperthermia added to chemoradiotherapy in advanced cervical cancer: Multicenter international feasibility. 21th Annual Meeting of the European Society for Hyperthermic Oncology; 2003-01-01 - 2003-06-07
UiB Untitled
 
36 Westermann, Anneke M.; Schem, Baard-Christian; Van der Zee, Jacoba; Jones, Ellen; Van der Steen-Banasik, Elzbieta; Mella, Olav; de Wit, Ronald; Uitterhoeve, Lon J.; Van der Wilt, C. L.; Prosnitz, Leonard R..
Regional hyperthermia added to chemoradiotherapy in advanced cervical cancer: Multicenter international feasibility. Thirty-Ninth Annual Meeting of the American Society of Clinical Oncology; 2003-05-31 - 2003-06-03
UiB Untitled
 
2002
37 Dahl, Olav; Mella, Olav.
Hyperthermia alone or combined with cisplatin in addition to radiotherapy for advanced uterine cervical cancer. International Journal of Hyperthermia 2002 ;Volum 18.(1) s. 25-30
UiB Untitled
 
38 Muren, Ludvig; Mella, Olav; Hafslund, Rune; Dahl, Olav.
Norwegian Oncologists' Expectations of Intensity-modulated Radiotherapy. Acta Oncologica 2002 ;Volum 41.(6) s. 562-565
UiB Untitled
 
2001
39 Eikesdal, Hans Petter; Bjerkvig, Rolf; Mella, Olav; Dahl, Olav.
Combretastatin A-4 and hyperthermia; a potent combination for the treatment of solid tumors. Radiotherapy and Oncology 2001 ;Volum 60. s. 147-154
UiB Untitled
 
40 Eikesdal, Hans Petter; Bjerkvig, Rolf; Raleigh, James A.; Mella, Olav; Dahl, Olav.
Tumor vasculature is targeted by the combination of combretastatin A-4 and hyperthermia. Radiotherapy and Oncology 2001 ;Volum 61. s. 313-320
UiB Untitled
 
41 Lønning, Per Eystein; Taylor, Paul D.; Anker, Gun; Iddon, Julie; Wie, Liv; Jørgensen, Linn-Marie; Mella, Olav; Howell, Anthony.
High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy. Breast Cancer Research and Treatment 2001 ;Volum 67. s. 111-116
UiB Untitled
 
42 Muren, Ludvig; Mella, Olav; Hafslund, R.; Dahl, Olav.
National survey of IMRT expectations in Norway. 4th Nordic Conference on Radiation Oncology; 2001-06-07 - 2001-06-09
UiB Untitled
 
43 Schem, Baard-Christian; Frøystein, T.; Hjertaker, B. T.; Dahl, Olav; Mella, Olav.
Regional Hyperthermia as part of trimodality treatment of locally advanced/locally recurrent cervical carcinoma, and primarily inoperable/locally recurrent carcinoma. 19th Meeting of the European Society of Hyperthermic Oncology; 2001-05-30 - 2001-06-02
UiB Untitled
 
2000
44 Eikesdal, Hans Petter; Schem, Baard Christian; Mella, Olav; Dahl, Olav.
The new tubulin-inhibitor combretastatin A-4 enhances thermal damage in the BT4An rat glioma. International Journal of Radiation Oncology, Biology, Physics 2000 ;Volum 46. s. 645-652
UiB Untitled
 
45 Eikesdal, Hans Petter; Schem, Baard-Christian; Mella, Olav; Dahl, Olav.
The new tubulin-inhibitor combretastatin A-4 enhances thermal damage in the BT4An rat glioma. International Journal of Radiation Oncology, Biology, Physics 2000 ;Volum 46. s. 645-652
UiB Untitled
 
1999
46 Dahl, Olav; Dalene, Ronny; Schem, Baard Christian; Mella, Olav.
Status of clinical hyperthermia. Acta Oncologica 1999 ;Volum 38. s. 863-873
UiB Untitled
 
47 Mella, Olav; Melien, Ø; Bjordal, K; Kaasa, S.
Kvalme og oppkast ved cytostaticabehandling. I: Cytostatika. Medikamentell kreftbehandling [6. utg.]. Oslo: Institutt for farmakoterapi , UiO/Den Norske Kreftforening 1999 s. 96-103
UiB Untitled
 
48 Mella, Olav; Melien, Øyvind; Bjordal, Kristin; Kaasa, Stein.
Cytostatika Medikamentell kreftbehandling kap. 8 Kvalme og oppkast ved cytostatikabehandling. : Institutt for farmakoterapi og Den Norske Kreftforening 1999 ;Volum 6.430 s. Cytostatika -Medikamentell kreftbehandling
UiB UiO Untitled
 
49 Wisløff, F; Mella, Olav; Dahl, IM.
Myelomatose. I: Cytostatika. Medikamentell kreftbehandling [6. utg.]. Oslo: Institutt for farmakoterapi , UiO/Den Norske Kreftforening 1999 s. 299-303
UiB Untitled
 
1998
50 Guttormsen, Anne Berit; Ueland, Per Magne; Lønning, Per Eystein; Mella, Olav; Refsum, Helga.
Kinetics of plasma total homocysteine in patients receiving high- dose methotrexate therapy. Clinical Chemistry 1998 ;Volum 44.(9) s. 1987-1989
UiB Untitled
 
    Vis neste liste